Gene · 3702
Papers2,789
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 2,789
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Proline Isomerization: From the Chemistry and Biology to Therapeutic Opportunities. | Biology (Basel) | 2023 | 37508437 | PubTator, text mining | PubMed |
| Immunomodulatory role of spleen tyrosine kinase in chronic inflammatory and autoimmune diseases. | Immun Inflamm Dis | 2023 | 37506139 | PubTator, text mining | PubMed |
| T memory stem cell characteristics in autoimmune diseases and their promising therapeutic values. | Front Immunol | 2023 | 37497231 | PubTator, text mining | PubMed |
| CD3D and CD247 are the molecular targets of septic shock. | Medicine (Baltimore) | 2023 | 37478215 | PubTator, text mining | PubMed |
| Case report: Multiple epstein-barr virus-associated smooth muscle tumours in a child with IL-2-inducible T-cell kinase mutation of undetermined clinical significance. | Front Pediatr | 2023 | 37465420 | PubTator, text mining | PubMed |
| An appraisal of studies using mouse models to assist the biomarker discovery for sepsis prognosis. | Heliyon | 2023 | 37456011 | PubTator, text mining | PubMed |
| The Evolutionary Scenario of Pediatric Unclassified Primary Antibody Deficiency to Adulthood. | J Clin Med | 2023 | 37445241 | PubTator, text mining | PubMed |
| Complex interactions of cellular players in chronic Graft-versus-Host Disease. | Front Immunol | 2023 | 37435079 | PubTator, text mining | PubMed |
| Editorial: Novel targeted drugs for indolent lymphoid malignancies. | Front Oncol | 2023 | 37434970 | PubTator, text mining | PubMed |
| How molecular advances may improve the diagnosis and management of PTCL patients. | Front Oncol | 2023 | 37427095 | PubTator, text mining | PubMed |
| Aortic dissection induced by vascular endothelial growth factor inhibitors. | Front Pharmacol | 2023 | 37426822 | PubTator, text mining | PubMed |
| Unresolved questions in selection of therapies for treatment-naïve chronic lymphocytic leukemia. | J Hematol Oncol | 2023 | 37422670 | PubTator, text mining | PubMed |
| IL2-inducible T-cell Kinase is Required for HBV-induced Type T Interferon Expression and Antiviral Response. | J Clin Transl Hepatol | 2023 | 37408826 | PubTator, text mining | PubMed |
| Enhancing the anticancer immune response with the assistance of drug repurposing and delivery systems. | Clin Transl Med | 2023 | 37403792 | PubTator, text mining | PubMed |
| Detailed safety profile of acalabrutinib vs ibrutinib in previously treated chronic lymphocytic leukemia in the ELEVATE-RR trial. | Blood | 2023 | 37390310 | PubTator, text mining | PubMed |
| Immunodeficiency with susceptibility to lymphoma with complex genotype affecting energy metabolism (FBP1, ACAD9) and vesicle trafficking (RAB27A). | Front Immunol | 2023 | 37388727 | PubTator, text mining | PubMed |
| Overexpression of DBT suppresses the aggressiveness of renal clear cell carcinoma and correlates with immune infiltration. | Front Immunol | 2023 | 37383233 | PubTator, text mining | PubMed |
| Nerve trunk healing and neuroma formation after nerve transection injury. | Front Neurol | 2023 | 37377855 | PubTator, text mining | PubMed |
| Risk of Infections Secondary to the Use of Targeted Therapies in Hematological Malignancies. | Life (Basel) | 2023 | 37374055 | PubTator, text mining | PubMed |
| Treatment Refractoriness in Chronic Lymphocytic Leukemia: Old and New Molecular Biomarkers. | Int J Mol Sci | 2023 | 37373521 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3702/papers?page=14